Pathways

Pilocarpine, commonly known as Isopto Carpine, is a muscarinic cholinergic agonist that regularly comes as an eye drop for intraocular pressure, Glaucoma, or to induce miosis. Pilocarpine is an agonist of muscarinic acetylcholine receptors subtype M1, M2, and M3. It is also a partial agonist for M4 muscarinic acetylcholine receptor. However approximately 60% to 75% of muscarinic acetylcholine receptors in the ciliary and iris sphincter muscles of the eye are the M3 subtype. By activating these receptors, the iris and ciliary muscles contract causing miosis, spasm of accommodation, and may cause a rise in intraocular pressure followed by a persistent fall. Muscarinic acetylcholine receptors M3 are coupled to the Gq signaling cascade. The activation of this leads to the acitvation of phospholipase C, which converts Phosphatidylinositol (3,4,5)-trisphosphate to inositol (3,4,5)-trisphosphate (IP3) and diacylglycerol (DAG). IP3 activates IP3 receptors on the sarcoplasmic reticulum leading to the release of stored calcium into the cytosol. DAG activates protein kinase C (PKC). One of the downstream effects of PKC include activation of calcium channels on the membrane, leading to influx of calcium ions into the cytosol. Both IP3 and DAG increase cytosolic levels of calcium which then binds to calmodulin to create a calcium-calmodulin complex. This complex activates myosin kinase. Muscle contraction and relaxation are controlled by the enzymes myosin kinase and myosin phosphatase. Myosin kinase phosphorylates myosin light chain, leading to interaction between actin and myosin, producing muscle contraction. Myosin phosphorylase dephosphorylates the phosphorylated myosin light chain, preventing interaction with actin, producing muscle relaxation. The calcium-calmodulin activates myosin kinase, leading to increased phosphorylation of myosin light chain and more muscle contraction. The activation of muscarinic acetylcholine receptor M3 continues to activate myosin kinase which leads to continued contractions of the ciliary or iris sphincter muscles. Pilocarpine is also an agonist of the muscarinic acetylcholine receptors M1, M2, and M4, however, they are much less present within the ciliary and iris sphincter muscles. M1 is also Gq coupled so has the same mechanism. M2 and M4 inhibit Adenylate cyclase, but that is not important in the contraction of the eye muscles. Pilocarpine is also only a partial agonist of M4.

Pilocarpine is a muscarinic cholinergic agonist used on the eye to treat elevated intraocular pressure, various types of glaucoma, and to induce miosis. Also available orally to treat symptoms of dry mouth associated with Sjogren's syndrome and radiotherapy. It is administered as an oral tablet for uses of dry mouth, which the M1 receptor target is responsible for. It is a slowly hydrolyzed muscarinic agonist with no nicotinic effects. Pilocarpine is used as a miotic and in the treatment of glaucoma. Pilocarpine, in appropriate dosage, can increase secretion by the exocrine glands. The sweat, salivary, lacrimal, gastric, pancreatic, and intestinal glands and the mucous cells of the respiratory tract may be stimulated. Pilocarpine is a cholinergic parasympathomimetic agent. It increase secretion by the exocrine glands, and produces contraction of the iris sphincter muscle and ciliary muscle (when given topically to the eyes) by mainly stimulating muscarinic receptors. By targeting the M1 receptor, saliva is produced helping with dry mouth.

Pilocarpine is a muscarinic cholinergic agonist used on the eye to treat elevated intraocular pressure, various types of glaucoma, and to induce miosis. Also available orally to treat symptoms of dry mouth associated with Sjogren's syndrome and radiotherapy. When used to treat glaucoma it is administered as an eye drop. Pilocarpine is a slowly hydrolyzed muscarinic agonist with no nicotinic effects. Pilocarpine is used as a miotic and in the treatment of glaucoma. When applied topically to the eye as a single dose it causes miosis, spasm of accommodation, and may cause a transitory rise in intraocular pressure followed by a more persistent fall. Pilocarpine is a cholinergic parasympathomimetic agent. It increase secretion by the exocrine glands, and produces contraction of the iris sphincter muscle and ciliary muscle (when given topically to the eyes) by mainly stimulating muscarinic receptors. Stimulation of the M2 receptors specifically causes the contraction of the ciliary muscles of the eye.

Pilocarpine, commonly known as Isopto Carpine, is a muscarinic cholinergic agonist that regularly comes as an eye drop for intraocular pressure, Glaucoma, or to induce miosis. Pilocarpine is an agonist of muscarinic acetylcholine receptors subtype M1, M2, and M3. It is also a partial agonist for M4 muscarinic acetylcholine receptor. However approximately 60% to 75% of muscarinic acetylcholine receptors in the ciliary and iris sphincter muscles of the eye are the M3 subtype. By activating these receptors, the iris and ciliary muscles contract causing miosis, spasm of accommodation, and may cause a rise in intraocular pressure followed by a persistent fall. Muscarinic acetylcholine receptors M3 are coupled to the Gq signaling cascade. The activation of this leads to the acitvation of phospholipase C, which converts Phosphatidylinositol (3,4,5)-trisphosphate to inositol (3,4,5)-trisphosphate (IP3) and diacylglycerol (DAG). IP3 activates IP3 receptors on the sarcoplasmic reticulum leading to the release of stored calcium into the cytosol. DAG activates protein kinase C (PKC). One of the downstream effects of PKC include activation of calcium channels on the membrane, leading to influx of calcium ions into the cytosol. Both IP3 and DAG increase cytosolic levels of calcium which then binds to calmodulin to create a calcium-calmodulin complex. Muscle contraction and relaxation are controlled by the enzymes myosin kinase and myosin phosphatase. Myosin kinase phosphorylates myosin light chain, leading to interaction between actin and myosin, producing muscle contraction. Myosin phosphorylase dephosphorylates the phosphorylated myosin light chain, preventing interaction with actin, producing muscle relaxation. The calcium-calmodulin activates myosin kinase, leading to increased phosphorylation of myosin light chain and more muscle contraction. The activation of muscarinic acetylcholine receptor M3 continues to activate myosin kinase which leads to continued contractions of the ciliary or iris sphincter muscles. Pilocarpine is also an agonist of the muscarinic acetylcholine receptors M1, M2, and M4, however, they are much less present within the ciliary and iris sphincter muscles. M1 is also Gq coupled so has the same mechanism. M2 and M4 inhibit Adenylate cyclase, but that is not important in the contraction of the eye muscles. Pilocarpine is also only a partial agonist of M4. Pilocarpine is typically administered as an opyhalmalic solution, but comes in tablet form as well. Some side effects of using pilocarpine may include cheat pain, fainting, headache, and nausea.